Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ji-wen ZhangfiledCriticalji-wen Zhang
Publication of TW200612980ApublicationCriticalpatent/TW200612980A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
The present invention relates to soluble CD26 or a biologically active variant of the soluble CD26 that effectively inhibits angiogenesis and inflammation in a mammalian subject, pharmaceutical compositions comprising the soluble CD26 and the use of soluble CD26 in methods of treatment.
TW094129079A2004-08-262005-08-25Use of soluble CD26 as inhibitor of angiogenesis and inflammation
TW200612980A
(en)